Page last updated: 2024-09-05

tolvaptan and Abdominal Aortic Aneurysm

tolvaptan has been researched along with Abdominal Aortic Aneurysm in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chang, WH; Lu, HY; Shih, CC; Wu, TC1
SoRelle, R1

Other Studies

2 other study(ies) available for tolvaptan and Abdominal Aortic Aneurysm

ArticleYear
Tolvaptan reduces angiotensin II-induced experimental abdominal aortic aneurysm and dissection.
    Vascular pharmacology, 2022, Volume: 144

    Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Disease Models, Animal; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Knockout, ApoE; Tolvaptan

2022
Rofecoxib use increases acute myocardial infarction risk.
    Circulation, 2004, May-04, Volume: 109, Issue:17

    Topics: Aortic Aneurysm, Abdominal; Benzazepines; Cardiology; Cholesterol; Female; Heart Failure; Humans; Lactones; Male; Myocardial Infarction; Seasons; Sulfones; Tolvaptan

2004